{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:42:28Z","timestamp":1791412948985,"version":"4.3.3"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,5,11]],"date-time":"2016-05-11T00:00:00Z","timestamp":1462924800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s00280-016-3045-3","type":"journal-article","created":{"date-parts":[[2016,5,11]],"date-time":"2016-05-11T03:22:26Z","timestamp":1462936946000},"page":"673-683","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":81,"title":["Mitochondria: Inadvertent targets in chemotherapy-induced skeletal muscle toxicity and wasting?"],"prefix":"10.1007","volume":"78","author":[{"given":"James C.","family":"Sorensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice D.","family":"Cheregi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cara A.","family":"Timpani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kulmira","family":"Nurgali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Rybalka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,11]]},"reference":[{"key":"3045_CR1","volume-title":"World Cancer Report 2014","author":"B Steward","year":"2014","unstructured":"Steward B, Wild C (2014) World Cancer Report 2014. International Agency for Research on Cancer, Lyon"},{"issue":"16","key":"3045_CR2","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1200\/JCO.2000.18.16.2938","volume":"18","author":"AD Gramont de","year":"2000","unstructured":"de Gramont AD et al (2000) Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18(16):2938\u20132947","journal-title":"J Clin Oncol"},{"issue":"5","key":"3045_CR3","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0960-9776(03)00106-1","volume":"12","author":"KN Ogston","year":"2003","unstructured":"Ogston KN et al (2003) A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival. The Breast 12(5):320\u2013327","journal-title":"The Breast"},{"issue":"1","key":"3045_CR4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nri2216","volume":"8","author":"L Zitvogel","year":"2008","unstructured":"Zitvogel L et al (2008) Immunological aspects of cancer chemotherapy. Nat Rev Immunol 8(1):59\u201373","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"3045_CR5","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1089\/ars.2011.3965","volume":"15","author":"LAA Gilliam","year":"2011","unstructured":"Gilliam LAA, St. Clair DK (2011) Chemotherapy-induced weakness and fatigue in skeletal muscle: the role of oxidative stress. Antioxid Redox Signal 15(9):2543\u20132563","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"3045_CR6","first-page":"57","volume":"2","author":"D Greene","year":"1993","unstructured":"Greene D et al (1993) A comparison of patient-reported side effects among three chemotherapy regimens for breast cancer. Cancer Pract 2(1):57\u201362","journal-title":"Cancer Pract"},{"issue":"1","key":"3045_CR7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1152\/physrev.00043.2011","volume":"93","author":"H Yin","year":"2013","unstructured":"Yin H, Price F, Rudnicki MA (2013) Satellite cells and the muscle stem cell niche. Physiol Rev 93(1):23\u201367","journal-title":"Physiol Rev"},{"issue":"1","key":"3045_CR8","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/pbc.24049","volume":"59","author":"LS J\u00e4rvel\u00e4","year":"2012","unstructured":"J\u00e4rvel\u00e4 LS et al (2012) Effects of a home-based exercise program on metabolic risk factors and fitness in long-term survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 59(1):155\u2013160","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"3045_CR9","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/13638490500523150","volume":"9","author":"M Brussel van","year":"2006","unstructured":"van Brussel M et al (2006) Physical function and fitness in long-term survivors of childhood leukaemia. Pediatr Rehabil 9(3):267\u2013274","journal-title":"Pediatr Rehabil"},{"key":"3045_CR10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3389\/fphar.2013.00049","volume":"4","author":"C Scheede-Bergdahl","year":"2013","unstructured":"Scheede-Bergdahl C, Jagoe RT (2013) After the chemotherapy: potential mechanisms for chemotherapy-induced delayed skeletal muscle dysfunction in survivors of acute lymphoblastic leukaemia in childhood. Front Pharmacol 4:49. doi: 10.3389\/fphar.2013.00049","journal-title":"Front Pharmacol"},{"issue":"6","key":"3045_CR11","doi-asserted-by":"crossref","first-page":"e0129742","DOI":"10.1371\/journal.pone.0129742","volume":"10","author":"Y Miyamoto","year":"2015","unstructured":"Miyamoto Y et al (2015) Negative impact of skeletal muscle loss after systemic chemotherapy in patients with unresectable colorectal cancer. PLoS ONE 10(6):e0129742","journal-title":"PLoS ONE"},{"issue":"14","key":"3045_CR12","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1113\/jphysiol.2012.230185","volume":"590","author":"S Larsen","year":"2012","unstructured":"Larsen S et al (2012) Biomarkers of mitochondrial content in skeletal muscle of healthy young human subjects. J Physiol 590(14):3349\u20133360","journal-title":"J Physiol"},{"issue":"3","key":"3045_CR13","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/MCO.0000000000000164","volume":"18","author":"JM Argil\u00e9s","year":"2015","unstructured":"Argil\u00e9s JM, L\u00f3pez-Soriano FJ, Busquets S (2015) Muscle wasting in cancer: the role of mitochondria. Curr Opin Clin Nutr Metab Care 18(3):221\u2013225","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"4","key":"3045_CR14","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1470-2045(13)70055-X","volume":"14","author":"AS Dobs","year":"2013","unstructured":"Dobs AS et al (2013) Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial. Lancet Oncol 14(4):335\u2013345","journal-title":"Lancet Oncol"},{"issue":"7","key":"3045_CR15","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/pbc.21091","volume":"49","author":"KK Ness","year":"2007","unstructured":"Ness KK et al (2007) Body composition, muscle strength deficits and mobility limitations in adult survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 49(7):975\u2013981","journal-title":"Pediatr Blood Cancer"},{"issue":"7","key":"3045_CR16","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0006-2952(98)00307-4","volume":"57","author":"D Gewirtz","year":"1999","unstructured":"Gewirtz D (1999) A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem Pharmacol 57(7):727\u2013741","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"3045_CR17","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/mus.21809","volume":"43","author":"LA Gilliam","year":"2011","unstructured":"Gilliam LA et al (2011) Doxorubicin causes diaphragm weakness in murine models of cancer chemotherapy. Muscle Nerve 43(1):94\u2013102","journal-title":"Muscle Nerve"},{"issue":"6","key":"3045_CR18","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s00280-008-0890-8","volume":"63","author":"WR Schelman","year":"2009","unstructured":"Schelman WR et al (2009) A phase I study of Triapine\u00ae in combination with doxorubicin in patients with advanced solid tumors. Cancer Chemother Pharmacol 63(6):1147\u20131156","journal-title":"Cancer Chemother Pharmacol"},{"issue":"3","key":"3045_CR19","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1053\/j.semnuclmed.2005.02.005","volume":"35","author":"P Lu","year":"2005","unstructured":"Lu P (2005) Monitoring cardiac function in patients receiving doxorubicin. Semin Nucl Med 35(3):197\u2013201","journal-title":"Semin Nucl Med"},{"key":"3045_CR20","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ijbiomac.2014.02.028","volume":"66","author":"D Agudelo","year":"2014","unstructured":"Agudelo D et al (2014) Intercalation of antitumor drug doxorubicin and its analogue by DNA duplex: structural features and biological implications. Int J Biol Macromol 66:144\u2013150","journal-title":"Int J Biol Macromol"},{"issue":"1 Supplement","key":"3045_CR21","doi-asserted-by":"crossref","first-page":"966.1","DOI":"10.1096\/fasebj.28.1_supplement.966.1","volume":"28","author":"B Quach","year":"2014","unstructured":"Quach B, Birk A, Szeto H (2014) Mechanism of preventing doxorubicin-induced mitochondrial toxicity with cardiolipin-targeted peptide, SS-31 (966.1). FASEB J 28(1 Supplement):966.1","journal-title":"FASEB J"},{"issue":"Supplement 2","key":"3045_CR22","doi-asserted-by":"crossref","first-page":"S202","DOI":"10.1016\/j.nmd.2015.06.069","volume":"25","author":"B Cheregi","year":"2015","unstructured":"Cheregi B et al (2015) Chemotherapy-induced mitochondrial respiratory dysfunction, oxidant production and death in healthy skeletal muscle C2C12 myoblast and myotube models. Neuromuscul Disord 25(Supplement 2):S202","journal-title":"Neuromuscul Disord"},{"key":"3045_CR23","doi-asserted-by":"crossref","first-page":"645460","DOI":"10.1155\/2012\/645460","volume":"2012","author":"DG Deavall","year":"2012","unstructured":"Deavall DG et al (2012) Drug-induced oxidative stress and toxicity. J Toxicol 2012:645460","journal-title":"J Toxicol"},{"issue":"2","key":"3045_CR24","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.pcad.2010.06.007","volume":"53","author":"DB Sawyer","year":"2010","unstructured":"Sawyer DB et al (2010) Mechanisms of anthracycline cardiac injury: Can we identify strategies for cardioprotection? Prog Cardiovasc Dis 53(2):105\u2013113","journal-title":"Prog Cardiovasc Dis"},{"issue":"12","key":"3045_CR25","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.tcb.2013.08.003","volume":"23","author":"KA Sarosiek","year":"2013","unstructured":"Sarosiek KA, Chonghaile TN, Letai A (2013) Mitochondria: gatekeepers of response to chemotherapy. Trends Cell Biol 23(12):612\u2013619","journal-title":"Trends Cell Biol"},{"issue":"10","key":"3045_CR26","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nrc3365","volume":"12","author":"DC Wallace","year":"2012","unstructured":"Wallace DC (2012) Mitochondria and cancer. Nat Rev Cancer 12(10):685\u2013698","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"3045_CR27","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1152\/physrev.00026.2013","volume":"94","author":"DB Zorov","year":"2014","unstructured":"Zorov DB, Juhaszova M, Sollott SJ (2014) Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol Rev 94(3):909\u2013950","journal-title":"Physiol Rev"},{"issue":"7","key":"3045_CR28","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1016\/S0021-9258(17)35746-0","volume":"261","author":"K Davies","year":"1986","unstructured":"Davies K, Doroshow J (1986) Redox cycling of anthracyclines by cardiac mitochondria. I. Anthracycline radical formation by NADH dehydrogenase. J Biol Chem 261(7):3060\u20133067","journal-title":"J Biol Chem"},{"issue":"7","key":"3045_CR29","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1016\/S0021-9258(17)35747-2","volume":"261","author":"J Doroshow","year":"1986","unstructured":"Doroshow J, Davies K (1986) Redox cycling of anthracyclines by cardiac mitochondria. II. Formation of superoxide anion, hydrogen peroxide, and hydroxyl radical. J Biol Chem 261(7):3068\u20133074","journal-title":"J Biol Chem"},{"issue":"38","key":"3045_CR30","doi-asserted-by":"crossref","first-page":"36027","DOI":"10.1074\/jbc.M304854200","volume":"278","author":"Q Chen","year":"2003","unstructured":"Chen Q et al (2003) Production of reactive oxygen species by mitochondria central role of complex III. J Biol Chem 278(38):36027\u201336031","journal-title":"J Biol Chem"},{"issue":"3","key":"3045_CR31","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1124\/mi.7.3.6","volume":"7","author":"Y Chen","year":"2007","unstructured":"Chen Y et al (2007) Collateral damage in cancer chemotherapy: oxidative stress in nontargeted tissues. Mol Interv 7(3):147","journal-title":"Mol Interv"},{"issue":"3","key":"3045_CR32","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s13539-013-0104-z","volume":"4","author":"AJ Dirks-Naylor","year":"2013","unstructured":"Dirks-Naylor AJ et al (2013) The effects of acute doxorubicin treatment on proteome lysine acetylation status and apical caspases in skeletal muscle of fasted animals. J Cachexia Sarcopenia Muscle 4(3):239\u2013243","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"3045_CR33","doi-asserted-by":"crossref","first-page":"C195","DOI":"10.1152\/ajpcell.00217.2011","volume":"302","author":"LAA Gilliam","year":"2012","unstructured":"Gilliam LAA et al (2012) Doxorubicin acts via mitochondrial ROS to stimulate catabolism in C2C12 myotubes. Am J Physiol Cell Physiol 302:C195\u2013C202","journal-title":"Am J Physiol Cell Physiol"},{"issue":"2","key":"3045_CR34","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1124\/mol.105.013383","volume":"68","author":"X Xu","year":"2005","unstructured":"Xu X, Persson HL, Richardson DR (2005) Molecular pharmacology of the interaction of anthracyclines with iron. Mol Pharmacol 68(2):261\u2013271","journal-title":"Mol Pharmacol"},{"issue":"9","key":"3045_CR35","doi-asserted-by":"crossref","first-page":"e1002151","DOI":"10.1371\/journal.pcbi.1002151","volume":"7","author":"NA Finn","year":"2011","unstructured":"Finn NA, Findley HW, Kemp ML (2011) A switching mechanism in doxorubicin bioactivation can be exploited to control doxorubicin toxicity. PLoS Comput Biol 7(9):e1002151","journal-title":"PLoS Comput Biol"},{"issue":"7","key":"3045_CR36","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1111\/bph.12188","volume":"169","author":"HM Ismail","year":"2013","unstructured":"Ismail HM et al (2013) Inhibition of iPLA2\u03b2 and of stretch-activated channels by doxorubicin alters dystrophic muscle function. Br J Pharmacol 169(7):1537\u20131550","journal-title":"Br J Pharmacol"},{"issue":"4","key":"3045_CR37","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1177\/1534735404270335","volume":"3","author":"KA Conklin","year":"2004","unstructured":"Conklin KA (2004) Chemotherapy-associated oxidative stress: impact on chemotherapeutic effectiveness. Integr Cancer Ther 3(4):294\u2013300","journal-title":"Integr Cancer Ther"},{"issue":"4","key":"3045_CR38","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.cmet.2011.03.004","volume":"13","author":"P Bai","year":"2011","unstructured":"Bai P et al (2011) PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation. Cell Metab 13(4):461\u2013468","journal-title":"Cell Metab"},{"issue":"4","key":"3045_CR39","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/0304-4165(78)90312-4","volume":"543","author":"P Goodwin","year":"1978","unstructured":"Goodwin P et al (1978) The effect of gamma radiation and neocarzinostatin of NAD and ATP levels in mouse leukaemia cells. Biochimica et Biophysica Acta (BBA) Gen Subj 543(4):576\u2013582","journal-title":"Biochimica et Biophysica Acta (BBA) Gen Subj"},{"issue":"1","key":"3045_CR40","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1432-1033.1979.tb04225.x","volume":"101","author":"CJ Skidmore","year":"1979","unstructured":"Skidmore CJ et al (1979) The Involvement of poly (ADP-ribose) polymerase in the degradation of NAD caused by \u03b3-radiation and N-methyl-N-nitrosourea. Eur J Biochem 101(1):135\u2013142","journal-title":"Eur J Biochem"},{"issue":"4","key":"3045_CR41","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0006-291X(03)01483-9","volume":"308","author":"W Ying","year":"2003","unstructured":"Ying W, Garnier P, Swanson RA (2003) NAD+ repletion prevents PARP-1-induced glycolytic blockade and cell death in cultured mouse astrocytes. Biochem Biophys Res Commun 308(4):809\u2013813","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"3045_CR42","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1101\/gad.1199904","volume":"18","author":"WX Zong","year":"2004","unstructured":"Zong WX et al (2004) Alkylating DNA damage stimulates a regulated form of necrotic cell death. Genes Dev 18(11):1272\u20131282","journal-title":"Genes Dev"},{"issue":"2","key":"3045_CR43","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1128\/MCB.01766-07","volume":"28","author":"M Niere","year":"2008","unstructured":"Niere M et al (2008) Functional localization of two poly (ADP-ribose)-degrading enzymes to the mitochondrial matrix. Mol Cell Biol 28(2):814\u2013824","journal-title":"Mol Cell Biol"},{"issue":"6","key":"3045_CR44","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1111\/j.1471-4159.2007.05114.x","volume":"104","author":"Y Lai","year":"2008","unstructured":"Lai Y et al (2008) Identification of poly-ADP-ribosylated mitochondrial proteins after traumatic brain injury. J Neurochem 104(6):1700\u20131711","journal-title":"J Neurochem"},{"issue":"4","key":"3045_CR45","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.cmet.2011.03.013","volume":"13","author":"P Bai","year":"2011","unstructured":"Bai P et al (2011) PARP-2 regulates SIRT1 expression and whole-body energy expenditure. Cell Metab 13(4):450\u2013460","journal-title":"Cell Metab"},{"issue":"3","key":"3045_CR46","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1677\/JOE-09-0402","volume":"205","author":"K Devalaraja-Narashimha","year":"2010","unstructured":"Devalaraja-Narashimha K, Padanilam BJ (2010) PARP1 deficiency exacerbates diet-induced obesity in mice. J Endocrinol 205(3):243\u2013252","journal-title":"J Endocrinol"},{"key":"3045_CR47","doi-asserted-by":"crossref","first-page":"C1","DOI":"10.1152\/ajpcell.1998.275.1.C1","volume":"275","author":"JI Kourie","year":"1998","unstructured":"Kourie JI (1998) Interaction of reactive oxygen species with ion transport mechanisms. Am J Physiol Cell Physiol 275:C1\u2013C24","journal-title":"Am J Physiol Cell Physiol"},{"issue":"11","key":"3045_CR48","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/gerona\/58.11.M999","volume":"58","author":"C Leeuwenburgh","year":"2003","unstructured":"Leeuwenburgh C (2003) Role of apoptosis in sarcopenia. J Gerontol Ser A Biol Sci Med Sci 58(11):999\u20131001","journal-title":"J Gerontol Ser A Biol Sci Med Sci"},{"key":"3045_CR49","doi-asserted-by":"crossref","first-page":"R337","DOI":"10.1152\/ajpregu.00469.2004","volume":"288","author":"SK Powers","year":"2005","unstructured":"Powers SK, Kavazis AN, DeRuisseau KC (2005) Mechanisms of disuse muscle atrophy: role of oxidative stress. Am J Physiol Regul Integr Comp Physiol 288:R337\u2013R344","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"1","key":"3045_CR50","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1172\/JCI18330","volume":"113","author":"J Du","year":"2004","unstructured":"Du J et al (2004) Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions. J Clin Investig 113(1):115\u2013123","journal-title":"J Clin Investig"},{"key":"3045_CR51","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1152\/japplphysiol.00677.2010","volume":"110","author":"AJ Smuder","year":"2011","unstructured":"Smuder AJ et al (2011) Exercise protects against doxorubicin-induced oxidative stress and proteolysis in skeletal muscle. J Appl Physiol 110:935\u2013942","journal-title":"J Appl Physiol"},{"issue":"1","key":"3045_CR52","doi-asserted-by":"crossref","first-page":"227S","DOI":"10.1093\/jn\/129.1.227S","volume":"129","author":"SH Lecker","year":"1999","unstructured":"Lecker SH et al (1999) Muscle protein breakdown and the critical role of the ubiquitin\u2013proteasome pathway in normal and disease states. J Nutr 129(1):227S\u2013237S","journal-title":"J Nutr"},{"issue":"7","key":"3045_CR53","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1681\/ASN.2006010083","volume":"17","author":"SH Lecker","year":"2006","unstructured":"Lecker SH, Goldberg AL, Mitch WE (2006) Protein degradation by the ubiquitin\u2013proteasome pathway in normal and disease states. J Am Soc Nephrol 17(7):1807\u20131819","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"3045_CR54","first-page":"789","volume":"118","author":"C Bonnard","year":"2008","unstructured":"Bonnard C et al (2008) Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced insulin-resistant mice. J Clin Investig 118(2):789\u2013800","journal-title":"J Clin Investig"},{"issue":"2","key":"3045_CR55","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1006\/bbrc.1993.2135","volume":"195","author":"K Adachi","year":"1993","unstructured":"Adachi K et al (1993) A deletion of mitochondrial DNA in murine doxorubicin-induced cardiotoxicity. Biochem Biophys Res Commun 195(2):945\u2013951","journal-title":"Biochem Biophys Res Commun"},{"key":"3045_CR56","doi-asserted-by":"publisher","first-page":"8717","DOI":"10.1038\/srep08717","volume":"5","author":"G Gouspillou","year":"2015","unstructured":"Gouspillou G et al (2015) Anthracycline-containing chemotherapy causes long-term impairment of mitochondrial respiration and increased reactive oxygen species release in skeletal muscle. Sci Rep 5:8717. doi: 10.1038\/srep08717","journal-title":"Sci Rep"},{"issue":"2 Suppl 5","key":"3045_CR57","first-page":"4","volume":"25","author":"E Raymond","year":"1998","unstructured":"Raymond E et al (1998) Oxaliplatin: mechanism of action and antineoplastic activity. Semin Oncol 25(2 Suppl 5):4\u201312","journal-title":"Semin Oncol"},{"issue":"23","key":"3045_CR58","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1056\/NEJMoa032709","volume":"350","author":"T Andr\u00e9","year":"2004","unstructured":"Andr\u00e9 T et al (2004) Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350(23):2343\u20132351","journal-title":"N Engl J Med"},{"issue":"10","key":"3045_CR59","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1023\/A:1008213732429","volume":"9","author":"E Raymond","year":"1998","unstructured":"Raymond E et al (1998) Oxaliplatin: a review of preclinical and clinical studies. Ann Oncol 9(10):1053\u20131071","journal-title":"Ann Oncol"},{"issue":"11","key":"3045_CR60","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0003-9993(95)81033-1","volume":"76","author":"KK Talvensaari","year":"1995","unstructured":"Talvensaari KK et al (1995) Decreased isokinetic trunk muscle strength and performance in long-term survivors of childhood malignancies: correlation with hormonal defects. Arch Phys Med Rehabil 76(11):983\u2013988","journal-title":"Arch Phys Med Rehabil"},{"issue":"45","key":"3045_CR61","doi-asserted-by":"crossref","first-page":"7449","DOI":"10.1038\/sj.onc.1208047","volume":"23","author":"I Gourdier","year":"2004","unstructured":"Gourdier I et al (2004) Oxaliplatin-induced mitochondrial apoptotic response of colon carcinoma cells does not require nuclear DNA. Oncogene 23(45):7449\u20137457","journal-title":"Oncogene"},{"key":"3045_CR62","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1152\/physrev.00004.2006","volume":"87","author":"S Lutsenko","year":"2007","unstructured":"Lutsenko S et al (2007) Function and regulation of human copper-transporting ATPases. Physiol RevVol. 87:1011\u20131046","journal-title":"Physiol RevVol."},{"issue":"11","key":"3045_CR63","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.chembiol.2013.08.010","volume":"20","author":"SP Wisnovsky","year":"2013","unstructured":"Wisnovsky SP et al (2013) Targeting mitochondrial DNA with a platinum-based anticancer agent. Chem Biol 20(11):1323\u20131328","journal-title":"Chem Biol"},{"key":"3045_CR64","unstructured":"Stojanovska V, McQuade RM, Stewart M, Timpani CA, Sorensen J, Orbell J, Rybalka E, Nurgali K (2015) Platinum accumulation and changes in mitochondrial function of the longitudinal muscle & myenteric plexus following oxaliplatin administration. In: Proceedings of the Australian Physiology Society"},{"key":"3045_CR65","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.freeradbiomed.2013.08.191","volume":"65","author":"LAA Gilliam","year":"2013","unstructured":"Gilliam LAA et al (2013) The anticancer agent doxorubicin disrupts mitochondrial energy metabolism and redox balance in skeletal muscle. Free Radic Biol Med 65:988\u2013996","journal-title":"Free Radic Biol Med"},{"key":"3045_CR66","doi-asserted-by":"crossref","first-page":"E31","DOI":"10.1152\/ajpendo.00609.2011","volume":"303","author":"SK Powers","year":"2012","unstructured":"Powers SK et al (2012) Mitochondrial signaling contributes to disuse muscle atrophy. Am J Physiol Endocrinol Metab 303:E31\u2013E39","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"3045_CR67","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1152\/japplphysiol.00591.2011","volume":"111","author":"K Min","year":"2011","unstructured":"Min K et al (2011) Mitochondrial-targeted antioxidants protect skeletal muscle against immobilization-induced muscle atrophy. J Appl Physiol 111:1459\u20131466","journal-title":"J Appl Physiol"},{"key":"3045_CR68","doi-asserted-by":"crossref","first-page":"C138","DOI":"10.1152\/ajpcell.00181.2010","volume":"300","author":"K Singh","year":"2011","unstructured":"Singh K, Hood DA (2011) Effect of denervation-induced muscle disuse on mitochondrial protein import. American Physiol Cell Physiol 300:C138\u2013C145","journal-title":"American Physiol Cell Physiol"},{"issue":"8","key":"3045_CR69","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1113\/jphysiol.2014.286518","volume":"593","author":"K Min","year":"2015","unstructured":"Min K et al (2015) Increased mitochondrial emission of reactive oxygen species and calpain activation are required for doxorubicin-induced cardiac and skeletal muscle myopathy. J Physiol 593(8):2017\u20132036","journal-title":"J Physiol"},{"issue":"9","key":"3045_CR70","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1113\/jphysiol.2010.201327","volume":"589","author":"SK Powers","year":"2011","unstructured":"Powers SK, Talbert EE, Adhihetty PJ (2011) Reactive oxygen and nitrogen species as intracellular signals in skeletal muscle. J Physiol 589(9):2129\u20132138","journal-title":"J Physiol"},{"issue":"2","key":"3045_CR71","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.molcel.2012.09.025","volume":"48","author":"LA Sena","year":"2012","unstructured":"Sena LA, Chandel NS (2012) Physiological roles of mitochondrial reactive oxygen species. Mol Cell 48(2):158\u2013167","journal-title":"Mol Cell"},{"issue":"5","key":"3045_CR72","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.cmet.2012.10.005","volume":"16","author":"S Lokireddy","year":"2012","unstructured":"Lokireddy S et al (2012) The ubiquitin ligase Mul1 induces mitophagy in skeletal muscle in response to muscle-wasting stimuli. Cell Metab 16(5):613\u2013624","journal-title":"Cell Metab"},{"key":"3045_CR73","first-page":"142","volume":"46","author":"J Sorensen","year":"2015","unstructured":"Sorensen J, Timpani CA, Campelj D, Petersen AC, Hayes A, Rybalka E (2015) Idebenone protects against chemotherapy-induced skeletal muscle wasting and mitochondrial dysfunction in mice. Proc Aust Physiol Soc 46:142","journal-title":"Proc Aust Physiol Soc"},{"key":"3045_CR74","doi-asserted-by":"crossref","first-page":"C834","DOI":"10.1152\/ajpcell.00579.2003","volume":"287","author":"RW Jackman","year":"2004","unstructured":"Jackman RW, Kandarian SC (2004) The molecular basis of skeletal muscle atrophy. Am J Physiol Cell Physiol 287:C834\u2013C843","journal-title":"Am J Physiol Cell Physiol"},{"issue":"5","key":"3045_CR75","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1096\/fj.09-146308","volume":"24","author":"YC Jang","year":"2010","unstructured":"Jang YC et al (2010) Increased superoxide in vivo accelerates age-associated muscle atrophy through mitochondrial dysfunction and neuromuscular junction degeneration. FASEB J 24(5):1376\u20131390","journal-title":"FASEB J"},{"issue":"1","key":"3045_CR76","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1242\/dmm.010389","volume":"6","author":"P Bonaldo","year":"2013","unstructured":"Bonaldo P, Sandri M (2013) Cellular and molecular mechanisms of muscle atrophy. Dis Models Mech 6(1):25\u201339","journal-title":"Dis Models Mech"},{"key":"3045_CR77","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-94-007-2869-1_5","volume-title":"Advances in mitochondrial medicine","author":"G Lenaz","year":"2012","unstructured":"Lenaz G (2012) Mitochondria and reactive oxygen species. Which role in physiology and pathology? In: Scatena R, Bottoni P, Giardina B (eds) Advances in mitochondrial medicine. Springer, Dordrecht, pp 93\u2013136"},{"issue":"5","key":"3045_CR78","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1074\/jbc.M111.280156","volume":"287","author":"Y Kurihara","year":"2012","unstructured":"Kurihara Y et al (2012) Mitophagy plays an essential role in reducing mitochondrial production of reactive oxygen species and mutation of mitochondrial DNA by maintaining mitochondrial quantity and quality in yeast. J Biol Chem 287(5):3265\u20133272","journal-title":"J Biol Chem"},{"key":"3045_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2013.09.004","author":"BA Neel","year":"2013","unstructured":"Neel BA, Lin Y, Pessin JE (2013) Skeletal muscle autophagy: a new metabolic regulator. Trends Endocrinol Metab TEM. doi: 10.1016\/j.tem.2013.09.004","journal-title":"Trends Endocrinol Metab TEM"},{"issue":"8","key":"3045_CR80","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/sj.cdd.4400908","volume":"8","author":"M Maccarrone","year":"2001","unstructured":"Maccarrone M, Melino G, Finazzi-Agro A (2001) Lipoxygenases and their involvement in programmed cell death. Cell Death Differ 8(8):776\u2013784","journal-title":"Cell Death Differ"},{"issue":"5","key":"3045_CR81","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1179\/135100005X70224","volume":"10","author":"K England","year":"2005","unstructured":"England K, Cotter T (2005) Direct oxidative modifications of signalling proteins in mammalian cells and their effects on apoptosis. Redox Rep 10(5):237\u2013245","journal-title":"Redox Rep"},{"issue":"4","key":"3045_CR82","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/mus.20743","volume":"35","author":"JS Moylan","year":"2007","unstructured":"Moylan JS, Reid MB (2007) Oxidative stress, chronic disease, and muscle wasting. Muscle Nerve 35(4):411\u2013429","journal-title":"Muscle Nerve"},{"issue":"6","key":"3045_CR83","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s11906-009-0068-8","volume":"11","author":"M Ranek","year":"2009","unstructured":"Ranek M, Wang X (2009) Activation of the ubiquitin\u2013proteasome system in doxorubicin cardiomyopathy. Curr Hypertens Rep 11(6):389\u2013395","journal-title":"Curr Hypertens Rep"},{"key":"3045_CR84","first-page":"279","volume":"249","author":"RM Corradetti","year":"2014","unstructured":"Corradetti RM (2014) Chemotherapy-induced peripheral neuropathy. Chemotherapy 249:279","journal-title":"Chemotherapy"},{"issue":"1","key":"3045_CR85","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.mpmed.2007.10.003","volume":"36","author":"MJ Lind","year":"2008","unstructured":"Lind MJ (2008) Principles of cytotoxic chemotherapy. Medicine 36(1):19\u201323","journal-title":"Medicine"},{"issue":"2","key":"3045_CR86","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0277-5379(83)90418-2","volume":"19","author":"A Coates","year":"1983","unstructured":"Coates A et al (1983) On the receiving end\u2014patient perception of the side-effects of cancer chemotherapy. Eur J Cancer Clin Oncol 19(2):203\u2013208","journal-title":"Eur J Cancer Clin Oncol"},{"issue":"3","key":"3045_CR87","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.critrevonc.2004.05.001","volume":"51","author":"KS Courneya","year":"2004","unstructured":"Courneya KS et al (2004) Exercise issues in older cancer survivors. CritRev Oncol Hematol 51(3):249\u2013261","journal-title":"CritRev Oncol Hematol"},{"issue":"3","key":"3045_CR88","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3109\/0284186X.2013.819116","volume":"53","author":"P-PM Willemse","year":"2014","unstructured":"Willemse P-PM et al (2014) Abdominal visceral and subcutaneous fat increase, insulin resistance and hyperlipidemia in testicular cancer patients treated with cisplatin-based chemotherapy. Acta Oncol 53(3):351\u2013360","journal-title":"Acta Oncol"},{"key":"3045_CR89","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/cphy.c110029","volume":"2","author":"JA Kent-Braun","year":"2012","unstructured":"Kent-Braun JA, Fitts RH, Christie A (2012) Skeletal muscle fatigue. Compr Physiol 2:997\u20131044","journal-title":"Compr Physiol"},{"issue":"9","key":"3045_CR90","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1242\/jcs.093674","volume":"125","author":"BR MacIntosh","year":"2012","unstructured":"MacIntosh BR, Holash RJ, Renaud J-M (2012) Skeletal muscle fatigue\u2013regulation of excitation\u2013contraction coupling to avoid metabolic catastrophe. J Cell Sci 125(9):2105\u20132114","journal-title":"J Cell Sci"},{"issue":"6","key":"3045_CR91","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1152\/japplphysiol.00445.2013","volume":"115","author":"RA Jacobs","year":"2013","unstructured":"Jacobs RA et al (2013) Improvements in exercise performance with high-intensity interval training coincide with an increase in skeletal muscle mitochondrial content and function. J Appl Physiol 115(6):785\u2013793","journal-title":"J Appl Physiol"},{"issue":"5","key":"3045_CR92","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/sms.12483","volume":"26","author":"K Gejl","year":"2015","unstructured":"Gejl K et al. (2015) Repeated high-intensity exercise modulates Ca2+ sensitivity of human skeletal muscle fibers. Scand J Med Sci Sports 26(5):488\u201397","journal-title":"Scand J Med Sci Sports"},{"issue":"3","key":"3045_CR93","doi-asserted-by":"crossref","first-page":"505","DOI":"10.7600\/jpfsm.1.505","volume":"1","author":"Y Kano","year":"2012","unstructured":"Kano Y et al (2012) Mechanisms of exercise-induced muscle damage and fatigue: intracellular calcium accumulation. J Phys Fit Sports Med 1(3):505\u2013512","journal-title":"J Phys Fit Sports Med"},{"issue":"1 Supplement","key":"3045_CR94","doi-asserted-by":"crossref","first-page":"LB660","DOI":"10.1096\/fasebj.29.1_supplement.lb660","volume":"29","author":"D Hydock","year":"2015","unstructured":"Hydock D et al (2015) Protective effects of endurance or resistance training exercise on chemotherapy-induced skeletal muscle weakness and fatigue. FASEB J 29(1 Supplement):LB660","journal-title":"FASEB J"},{"issue":"suppl 4","key":"3045_CR95","doi-asserted-by":"crossref","first-page":"iv45","DOI":"10.1093\/neuonc\/nos203","volume":"14","author":"W Grisold","year":"2012","unstructured":"Grisold W, Cavaletti G, Windebank AJ (2012) Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention. Neuro-oncology 14(suppl 4):iv45\u2013iv54","journal-title":"Neuro-oncology"},{"issue":"4","key":"3045_CR96","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.arr.2013.07.003","volume":"12","author":"BT Wall","year":"2013","unstructured":"Wall BT, Dirks ML, van Loon LJC (2013) Skeletal muscle atrophy during short-term disuse: implications for age-related sarcopenia. Ageing Res Rev 12(4):898\u2013906","journal-title":"Ageing Res Rev"},{"issue":"3","key":"3045_CR97","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/apha.12225","volume":"210","author":"M Franchi","year":"2014","unstructured":"Franchi M et al (2014) Architectural, functional and molecular responses to concentric and eccentric loading in human skeletal muscle. Acta Physiol 210(3):642\u2013654","journal-title":"Acta Physiol"},{"issue":"7","key":"3045_CR98","doi-asserted-by":"crossref","first-page":"393","DOI":"10.4236\/ijcm.2014.57054","volume":"5","author":"RM McQuade","year":"2014","unstructured":"McQuade RM, Bornstein JC, Nurgali K (2014) Anti-colorectal cancer chemotherapy-induced diarrhoea: current treatments and side-effects. Int J Clin Med 5(7):393","journal-title":"Int J Clin Med"},{"key":"3045_CR99","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/1097-0142(19930701)72:1<276::AID-CNCR2820720148>3.0.CO;2-2","volume":"72","author":"L Hovi","year":"1993","unstructured":"Hovi L et al (1993) Impaired muscle strength in female adolescents and young adults surviving leukemia in childhood. Cancer Phila 72:276","journal-title":"Cancer Phila"},{"key":"3045_CR100","doi-asserted-by":"crossref","DOI":"10.5040\/9781492596837","volume-title":"Growth, maturation, and physical activity","author":"RM Malina","year":"2004","unstructured":"Malina RM, Bouchard C, Bar-Or O (2004) Growth, maturation, and physical activity. Human Kinetics, Champaign"},{"issue":"1","key":"3045_CR101","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-201X.2005.01417.x","volume":"184","author":"V Mouly","year":"2005","unstructured":"Mouly V et al (2005) The mitotic clock in skeletal muscle regeneration, disease and cell mediated gene therapy. Acta Physiol Scand 184(1):3\u201315","journal-title":"Acta Physiol Scand"},{"issue":"2","key":"3045_CR102","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s12012-007-0006-4","volume":"7","author":"RE Scully","year":"2007","unstructured":"Scully RE, Lipshultz SE (2007) Anthracycline cardiotoxicity in long-term survivors of childhood cancer. Cardiovasc Toxicol 7(2):122\u2013128","journal-title":"Cardiovasc Toxicol"},{"issue":"27","key":"3045_CR103","doi-asserted-by":"crossref","first-page":"6596","DOI":"10.1200\/JCO.2005.12.674","volume":"23","author":"KL Syrjala","year":"2005","unstructured":"Syrjala KL et al (2005) Late effects of hematopoietic cell transplantation among 10-year adult survivors compared with case-matched controls. J Clin Oncol 23(27):6596\u20136606","journal-title":"J Clin Oncol"},{"issue":"8","key":"3045_CR104","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1001\/archneurol.2010.168","volume":"67","author":"DR Lynch","year":"2010","unstructured":"Lynch DR, Perlman SL, Meier T (2010) A phase 3, double-blind, placebo-controlled trial of idebenone in Friedreich ataxia. Arch Neurol 67(8):941\u2013947","journal-title":"Arch Neurol"},{"issue":"5","key":"3045_CR105","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1055\/s-0028-1128142","volume":"41","author":"B Literati-Nagy","year":"2009","unstructured":"Literati-Nagy B et al (2009) Improvement of insulin sensitivity by a novel drug, BGP-15, in insulin-resistant patients: a proof of concept randomized double-blind clinical trial. Hormone Metab Res Hormon-und Stoffwechselforschung Hormones et metabolisme 41(5):374\u2013380","journal-title":"Hormone Metab Res Hormon-und Stoffwechselforschung Hormones et metabolisme"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-016-3045-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-016-3045-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-016-3045-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-016-3045-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T09:23:24Z","timestamp":1718529804000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-016-3045-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,11]]},"references-count":105,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["3045"],"URL":"https:\/\/doi.org\/10.1007\/s00280-016-3045-3","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,11]]}}}